Germany · Biopharma startup

c-LEcta

c-LEcta operates as a biotechnology company focusing on enzyme engineering and bioprocess development for regulated markets.

Funding reportedLast round: Undisclosed round

BiopharmaGermany

What company datasets say c-LEcta raised

Funding, as reported

Reported in all1.3Min the source's currency
Rounds4
Last roundUndisclosed round
Last round dateAug 2018
Investors listed5

Founders and team

From c-LEcta's own website: 1 founder, 5 on the team.

Dr. Marc StruhallaCEO and Founder
  • Carsten FietzSenior Vice President Finance & Administration
  • Dr. Andreas ButheVice President Business Development
  • Dr. Andreas VogelVice President R&D Enzyme Development
  • Dr. Ramona SchmiedelVice President QSHE & Compliance
  • Dr. Raphael GübeliVice President Marketing & Sales

Biopharma in Germany

Startups like it

Is this your company?

Add your raise, your deck and your story, and put c-LEcta in front of investors. Or tell us what we have wrong.

List your startupSend a correction